Physician profile
Boris Murillo
NPI 1730133737
$135,484.52
in general payments reported to CMS, 2019-2025
31 companies · $3,912 in 2025
The $3,912 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,017 · 2020: $17K · 2021: $15K · 2022: $31K · 2023: $20K · 2024: $42K · 2025: $3,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Education: $4,253 · Food and Beverage: $3,831 · Travel and Lodging: $3,263 · Consulting Fee: $200 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,750.00 |
| Education | $4,252.97 |
| Food and Beverage | $3,830.56 |
| Travel and Lodging | $3,262.94 |
| Consulting Fee | $200.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $112,797.75 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Intuitive Surgical, INC. | $19,840.71 | 2019-2025 | Da Vinci Surgical System, Ion |
| Genzyme Corporation | $600.34 | 2019-2025 | |
| Glaxosmithkline, LLC. | $361.76 | 2019-2025 | Nucala, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $325.00 | 2020-2023 | |
| Actelion Pharmaceuticals US, INC. | $220.91 | 2019-2025 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $182.98 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $170.83 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.50 | 2019-2024 | Ofev |
| Edwards Lifesciences Corporation | $106.83 | 2023 | Hemosphere |
| Regeneron Healthcare Solutions, INC. | $106.18 | 2023-2025 | Dupixent |
| Mylan Specialty L.P. | $80.38 | 2019 | |
| Sunovion Pharmaceuticals INC. | $80.10 | 2019 | |
| Philips North America LLC | $77.48 | 2019 | |
| Pulmonx Corporation | $61.38 | 2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $61.01 | 2019-2025 | |
| Mallinckrodt Enterprises LLC | $39.80 | 2019 | |
| Grifols USA, LLC | $33.73 | 2019 | |
| Olympus America INC. | $30.13 | 2019 | |
| Electromed, INC. | $27.85 | 2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $17.75 | 2019 | |
| Covidien Lp | $16.87 | 2019 | |
| Mayne Pharma Commercial LLC | $16.60 | 2019 | |
| Verona Pharma, INC. | $16.15 | 2025 | Ohtuvayre |
| Shire North American Group INC | $14.83 | 2019 | |
| United Therapeutics Corporation | $13.41 | 2023 | Tyvaso |
| Amgen INC. | $13.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.33 | 2019 | |
| Insmed, INC. | $12.08 | 2019 | |
| Genentech USA, INC. | $11.72 | 2019 | |
| Circassia INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Murillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.